Internal Medicine, Rheumatology · Des Plaines, IL
NPI
1669586079
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
150 N River Rd Ste 270
Des Plaines, IL, 60016
Phone (847) 298-8470
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
309,305 services
Medicare patients, 2024
602
Average age 77
Drug cost, 2024
$2.7M
4,122 prescriptions
Company payments, 2025
$666
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sergey Furmanov was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 177,000 times for 48 patients. In total Sergey Furmanov billed 309,305 services in 99 codes, and Medicare paid $2.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 177,000 | 48 | $3.62 | $640K |
| J3262 Injection, tocilizumab, 1 mg | Office | 36,064 | 15 | $4.70 | $169K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 30,228 | 37 | $9.05 | $274K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 13,232 | 13 | $8.56 | $113K |
| J0897 Injection, denosumab, 1 mg | Office | 12,540 | 124 | $20.48 | $257K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 11,862 | 44 | $24.79 | $294K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 8,650 | 12 | $32.05 | $277K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 1,269 | 113 | $0.52 | $655 |
| 96372 Injection Administration | Office | 1,222 | 174 | $9.91 | $12K |
| 99214 Office E&M - Established | Office | 1,151 | 541 | $86.58 | $100K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 911 | 365 | $45.48 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 740 | 424 | $11.51 | $8,521 |
| 36415 Venipuncture Blood Collection | Office | 696 | 399 | $2.96 | $2,057 |
| 85025 Blood Count | Office | 666 | 387 | $7.54 | $5,025 |
| 83735 Clinical Chemistry | Office | 663 | 387 | $6.52 | $4,319 |
By year: 2022 $2.8M for 277,707 services; 2023 $2.6M for 289,504 services; 2024 $2.6M for 309,305 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 696 | 399 | $2.96 | $2,057 |
| 85025 Blood Count | 666 | 387 | $7.54 | $5,025 |
| 83735 Clinical Chemistry | 663 | 387 | $6.52 | $4,319 |
| 80053 Clinical Chemistry | 661 | 386 | $10.26 | $6,783 |
| 85651 Clinical Chemistry | 656 | 391 | $4.14 | $2,718 |
| 82610 Clinical Chemistry | 650 | 384 | $17.99 | $12K |
| 86140 Clinical Chemistry | 642 | 383 | $5.04 | $3,233 |
| 82306 Clinical Chemistry | 333 | 279 | $29.01 | $9,660 |
| 86235 Immunoassay | 165 | 33 | $17.57 | $2,899 |
| 86431 Immunoassay | 54 | 53 | $5.47 | $296 |
Medicare prescription drug claims, 2024
In 2024, the drug Sergey Furmanov prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 676 prescriptions and refills. In total Sergey Furmanov wrote 4,122 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 676 | 1,653 | 171 | $22K |
| Prednisone Generic | 619 | 1,282 | 181 | $6,839 |
| Hydroxychloroquine Sulfate Generic | 386 | 951 | 112 | $13K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 173 | 173 | 50 | $6,447 |
| Tramadol Hcl Generic | 151 | 161 | 37 | $1,146 |
| Meloxicam Generic | 130 | 329 | 50 | $1,134 |
| Gabapentin Generic | 102 | 212 | 33 | $1,317 |
| Allopurinol Generic | 96 | 254 | 24 | $1,015 |
| Methylprednisolone Generic | 94 | 96 | 60 | $616 |
| Celecoxib Generic | 92 | 218 | 26 | $2,472 |
| Humira(Cf) Pen Adalimumab | 89 | 94 | 11 | $651K |
| Diclofenac Sodium Generic | 77 | 137 | 21 | $2,573 |
| Leflunomide Generic | 76 | 164 | 23 | $3,608 |
| Pilocarpine Hcl Generic | 68 | 177 | 27 | $3,772 |
| Xeljanz Xr Tofacitinib Citrate | 62 | 62 | Under 11 | $352K |
Brand drugs: - claims; generic drugs: 3,664 claims; opioid claims: 473.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sergey Furmanov $666 ($666 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $492.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.